Search for: "Does 1-27" Results 9121 - 9140 of 12,455
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Apr 2019, 3:50 am by Kevin Kaufman
Estonia 1 100.0% 1 100.0% 1 100.0% 1 100.0% Latvia 1 100.0% 1 100.0% 1 100.0% 1 100.0% Lithuania 3 89.5% 7 91.8% 3 83.8% 3 98.0% Slovak Republic 4 78.2% 11 87.4% 4 65.3% 6 87.0% Belgium 5 76.3% 9 88.2% 5 62.2% 17 80.3% Iceland 6 74.7% 16 86.0% 6 60.2% 16 81.2% Switzerland 7 74.1% 16 86.0% 7 55.5% 5 90.5% South Korea 8 74.0% 6 92.2% 8 54.8% 20 73.8% Czech Republic 9 73.3% 11 87.4% 12 54.3% 13 84.1% France 10 73.2% 19 85.8% 8… [read post]
7 Dec 2014, 6:06 am by Giles Peaker
But this does not mean that size is irrelevant. [read post]
5 Mar 2013, 9:25 am by Larry Catá Backer
”[12]Article 100 became Article 53 in the current 1984 version of the Constitution, and the language of the article remained mostly unchanged. [13] Article 53 deals with the duties of the citizens, it does not explicitly provide means for the state to exercise judicial authority. [read post]
3 Sep 2011, 12:36 pm by The Legal Blog
Generally stare decisis does not attach to such parts of an opinion of a court which are mere dicta. [read post]
2 Nov 2009, 5:03 pm
”[1] The issues at the root of DRM are by no means new, but have recently been exacerbated by the influx of the Internet and new technologies.[2] The current lack of an adequate means of regulation and the subsequent distribution of music and media by consumers has led to a great deal of litigation. [read post]
22 Nov 2015, 9:05 pm by Stephen Bilkis
The minor child does not have any relationship with his biological father. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
Four Myths about Biotech Securities Cases   As discussed in our original article, these findings overturn several longstanding myths about this subset of securities class actions:   Myth #1: Cases against biotech companies for failed clinical trials or products that are not approved by the FDA are risky and expensive. [read post]
20 Dec 2017, 3:11 pm
On 4 December 2017 the Office of the President of the United States released its national security strategy going forward, Office of the President of the United States, National Security Strategy of the United States (4 Dec. 2017) (hereafter the "NSS"). [read post]
20 Mar 2020, 1:58 am by Dennis Crouch
July 31–August 1, 2017 The PTAB instituted review on both of Facebook’s additional IPR petitions and allowed them to be joined to Facebook’s earlier IPRs. [read post]
3 Feb 2021, 5:27 am by Joel R. Brandes
Slip Op. 00352(3d Dept.,2021) the Appellate Division held that jurisdiction over a neglect proceeding does not depend upon the situs of the neglect. [read post]
3 Feb 2021, 5:31 am by Joel R. Brandes
Slip Op. 00352(3d Dept.,2021) the Appellate Division held that jurisdiction over a neglect proceeding does not depend upon the situs of the neglect. [read post]
22 Jan 2024, 1:10 am by INFORRM
Title II does not create a right to information. [read post]
10 Mar 2011, 9:49 am by The Legal Blog
In the background of the aforesaid discussion, this Court proceeds to examine the scope of a person's right under Section 5A of the Act.27. [read post]
22 Apr 2011, 8:16 am
The days in the Jewish calendar are what differ.Well, you ask, why does it matter? [read post]
29 Jul 2020, 9:48 am by Paul Cassell
We found that changes in 9-1-1 call rates could not explain the Chicago homicide spike. [read post]
9 Dec 2018, 4:12 pm by INFORRM
IPSO Rulings A ruling and two resolution statements have been published by IPSO’s Complaints Committee this week: 03137-18 Ashton v Daily Mail, principle 1 (accuracy), no breach after investigation 03996-18 Sanusi v Liverpool Echo, principles 1 and 2 (privacy), no breach after investigation 04524-18 McAlpine v The Scottish Sun, principles, 2, 3 (harassment), 4 (intrusion into grief and shock) and 10 (clandestine devices and subterfuge), no breach after investigation 05653-18… [read post]
31 Jul 2022, 9:05 pm by Jonan Pilet
  On July 27, the CDC declared its investigation of the Salmonella outbreak connected to J.M. [read post]